PLRX logo
PLRX NASDAQ US

Pliant Therapeutics, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jun 2020
$1.35
▲ +$0.03 (+2.27%)
Vol 522K
3
Quality Score
fail
Mkt Cap
$75.0M
ROE
-73.5%
Margin
-2871.2%
D/E
15.20
Beta
1.38
52W
$1–$14

Wall Street Consensus

11 analysts · Apr 2026
0
Strong Buy
1
Buy
6
Hold
2
Sell
2
Strong Sell
9.1%
Buy Rating

Price Chart

Similar Stocks

TTRX
Turn Therapeutics Inc
VRCA
Verrica Pharmaceuticals Inc
$78.9M
AARD
Aardvark Therapeutics Inc
$285.8M
RANI
Rani Therapeutics Holdings Inc
$164.1M
GRCE
Grace Therapeutics, Inc
$53.5M
CGTX
Cognition Therapeutics Inc
$119.2M
NRXP
NRX Pharmaceuticals Inc
$80.2M
CING
Cingulate Inc
$29.3M

Earnings

Beat rate: 50.0%
Next Report May 06, 2026
EPS Estimate: $-0.36
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.36 — —
Dec 2025 $-0.39 $-0.38 +$0.01
Sep 2025 $-0.53 $-0.43 +$0.10
Jun 2025 $-0.71 $-0.71 $0.00

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -73.5% -73.5% -73.5% -73.5% -73.5% -73.5%
P/E (TTM) — — — — — —
Net Margin — -2871.2% -2871.2% -2871.2% -2871.2% -2871.2%
Gross Margin — — — — — —
D/E Ratio 13.79 13.79 13.79 13.79 15.20 15.20
Current Ratio 12.99 12.99 12.99 12.99 13.93 13.93

Key Ratios

ROA (TTM)
-55.7%
P/S (TTM)
14.90
P/B
2.6
EPS (TTM)
$-3.39
CF/Share
$-2.74
52W High
$14.26
52W Low
$1.10
$1.10 52-Week Range $14.26

How does PLRX compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

PLRX AARD ACB ACRS ADIL

PLRX valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
14.9
▲ 201% above peers (5.0)
vs Peers
vs Industry
Pricier
P/B ratio
2.6
▲ 24% above peers (2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

PLRX profitability vs Pharmaceuticals peers

ROE
-73.5%
▼ 35% below peers (-54.3%)
vs Peers
vs Industry
Below avg
Net margin
-2871.2%
▼ 5961% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-55.7%
▼ 49% below peers (-37.4%)
vs Peers
vs Industry
Below avg

PLRX financial health vs Pharmaceuticals peers

D/E ratio
15.2
▲ 887% above peers (1.5)
vs Peers
vs Industry
Above avg
Current ratio
13.9
▲ 315% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.4
▲ 47% above peers (0.9)
vs Peers
vs Industry
More volatile

PLRX fundamentals radar

PLRX Peer median Industry

PLRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

PLRX vs peers: key metrics

Latest News

No related news yet